Baseline values of hs-TnT/I, calcium score, and clinical pretest probability according to sex and presence of fCAD
| . | Overall . | Women . | Men . | P-value* . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | Overall n = 1715 . | fCAD+ 23.3% . | fCAD− 76.7% . | Overall n = 753 . | fCAD+ 13.6% . | fCAD− 86.4% . | Overall n = 962 . | fCAD+ 30.9% . | fCAD− 69.1% . | . |
| Calcium score | 102 (4–477) | 585 (197–1379) | 46 (0–271) | 34 (0–261) | 475 (111–1027) | 22 (0–164) | 194 (22–675) | 623 (227–1527) | 101 (7–397) | <0.001 |
| hs-cTnT (ng/L) | 8 (5–15) | 12 (7–21) | 7 (5–13) | 7 (4–12) | 10 (7–17.8) | 7 (4–11) | 9 (6–17) | 13 (8–23) | 8 (5–14) | <0.001 |
| hs-cTnI (ng/L)a | 3.4 (2–6.2) | 5.3 (2–5.3) | 3 (2–5.3) | 3 (1.9–5) | 4.5 (3–8.1) | 2.9 (1.7–4.9) | 4 (2.1–7.5) | 6 (3.3–10.8) | 3.2 (2–6) | <0.001 |
| CPTP (%)a | 30 (20–50) | 50 (30–70) | 30 (20–50) | 30 (20–50) | 40 (20–60) | 30 (20–50) | 30 (20–60) | 50 (30–70) | 30 (20–50) | 0.002 |
| . | Overall . | Women . | Men . | P-value* . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | Overall n = 1715 . | fCAD+ 23.3% . | fCAD− 76.7% . | Overall n = 753 . | fCAD+ 13.6% . | fCAD− 86.4% . | Overall n = 962 . | fCAD+ 30.9% . | fCAD− 69.1% . | . |
| Calcium score | 102 (4–477) | 585 (197–1379) | 46 (0–271) | 34 (0–261) | 475 (111–1027) | 22 (0–164) | 194 (22–675) | 623 (227–1527) | 101 (7–397) | <0.001 |
| hs-cTnT (ng/L) | 8 (5–15) | 12 (7–21) | 7 (5–13) | 7 (4–12) | 10 (7–17.8) | 7 (4–11) | 9 (6–17) | 13 (8–23) | 8 (5–14) | <0.001 |
| hs-cTnI (ng/L)a | 3.4 (2–6.2) | 5.3 (2–5.3) | 3 (2–5.3) | 3 (1.9–5) | 4.5 (3–8.1) | 2.9 (1.7–4.9) | 4 (2.1–7.5) | 6 (3.3–10.8) | 3.2 (2–6) | <0.001 |
| CPTP (%)a | 30 (20–50) | 50 (30–70) | 30 (20–50) | 30 (20–50) | 40 (20–60) | 30 (20–50) | 30 (20–60) | 50 (30–70) | 30 (20–50) | 0.002 |
Variables are presented as median (IQR). CPTP, clinical pretest probability.
aDistinct n (patients with missing value are excluded for this analysis: hs-TnI, n = 1636; CPTP, n = 1658).
*P-value applies to difference between women and men.
Baseline values of hs-TnT/I, calcium score, and clinical pretest probability according to sex and presence of fCAD
| . | Overall . | Women . | Men . | P-value* . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | Overall n = 1715 . | fCAD+ 23.3% . | fCAD− 76.7% . | Overall n = 753 . | fCAD+ 13.6% . | fCAD− 86.4% . | Overall n = 962 . | fCAD+ 30.9% . | fCAD− 69.1% . | . |
| Calcium score | 102 (4–477) | 585 (197–1379) | 46 (0–271) | 34 (0–261) | 475 (111–1027) | 22 (0–164) | 194 (22–675) | 623 (227–1527) | 101 (7–397) | <0.001 |
| hs-cTnT (ng/L) | 8 (5–15) | 12 (7–21) | 7 (5–13) | 7 (4–12) | 10 (7–17.8) | 7 (4–11) | 9 (6–17) | 13 (8–23) | 8 (5–14) | <0.001 |
| hs-cTnI (ng/L)a | 3.4 (2–6.2) | 5.3 (2–5.3) | 3 (2–5.3) | 3 (1.9–5) | 4.5 (3–8.1) | 2.9 (1.7–4.9) | 4 (2.1–7.5) | 6 (3.3–10.8) | 3.2 (2–6) | <0.001 |
| CPTP (%)a | 30 (20–50) | 50 (30–70) | 30 (20–50) | 30 (20–50) | 40 (20–60) | 30 (20–50) | 30 (20–60) | 50 (30–70) | 30 (20–50) | 0.002 |
| . | Overall . | Women . | Men . | P-value* . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | Overall n = 1715 . | fCAD+ 23.3% . | fCAD− 76.7% . | Overall n = 753 . | fCAD+ 13.6% . | fCAD− 86.4% . | Overall n = 962 . | fCAD+ 30.9% . | fCAD− 69.1% . | . |
| Calcium score | 102 (4–477) | 585 (197–1379) | 46 (0–271) | 34 (0–261) | 475 (111–1027) | 22 (0–164) | 194 (22–675) | 623 (227–1527) | 101 (7–397) | <0.001 |
| hs-cTnT (ng/L) | 8 (5–15) | 12 (7–21) | 7 (5–13) | 7 (4–12) | 10 (7–17.8) | 7 (4–11) | 9 (6–17) | 13 (8–23) | 8 (5–14) | <0.001 |
| hs-cTnI (ng/L)a | 3.4 (2–6.2) | 5.3 (2–5.3) | 3 (2–5.3) | 3 (1.9–5) | 4.5 (3–8.1) | 2.9 (1.7–4.9) | 4 (2.1–7.5) | 6 (3.3–10.8) | 3.2 (2–6) | <0.001 |
| CPTP (%)a | 30 (20–50) | 50 (30–70) | 30 (20–50) | 30 (20–50) | 40 (20–60) | 30 (20–50) | 30 (20–60) | 50 (30–70) | 30 (20–50) | 0.002 |
Variables are presented as median (IQR). CPTP, clinical pretest probability.
aDistinct n (patients with missing value are excluded for this analysis: hs-TnI, n = 1636; CPTP, n = 1658).
*P-value applies to difference between women and men.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
